Comment on: Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta‐analysis
Special Care in Dentistry · 2024
DOI: 10.1111/scd.12909 ↗Kurz gefasst
Leserbrief in der Zeitschrift Special Care in Dentistry, 2024. Verfasst von Efsun Somay. Beteiligte Einrichtung: Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey. Hauptthemen laut MEDLINE: Bisphosphonate-Associated Osteonecrosis of the Jaw, Bone Density Conservation Agents, Denosumab, Diphosphonates. Die Arbeit nennt 5 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Baskent University, Ankara, Turkey.
ORCID-Profile: Efsun Somay
Zitieren
APA
Somay, E. (2024). Comment on: Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta‐analysis. Special Care in Dentistry. https://doi.org/10.1111/scd.12909
Vancouver
Somay E. Comment on: Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta‐analysis. Special Care in Dentistry. 2024. doi:10.1111/scd.12909
BibTeX
@article{Somay2024,
author = {Somay, Efsun},
title = {Comment on: Incidence rate of osteonecrosis of jaw after cancer treated with bisphosphonates and denosumab: A systematic review and meta‐analysis},
journal = {Special Care in Dentistry},
year = {2024},
doi = {10.1111/scd.12909}
}
EUVIMED